AtriCure director B. Kristine Johnson sells 2,452 shares

The reported weighted-average sale price was based on multiple trades priced from $58.23 to $58.86 per share.

Available on EDGAR 11/10/2026 - 04:03 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:02 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AtriCure, Inc. director B. Kristine Johnson sold 2,452 shares of common stock on November 6, 2026, at a reported weighted-average price of $58.48 per share. She directly held 53,502 shares after the transaction. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 2,452 shares

Net Sell 1 txn

Insider JOHNSON B KRISTINE

Role Director

Sold 2,452 shs ($143K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	2,452	$58.48	$143K

Holdings After Transaction: Common Stock — 53,502 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $58.23 to $58.86 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 2,452 shares Weighted-average sale price: $58.48 per share Sale price range: $58.23 to $58.86 per share +1 more

4 metrics

Shares sold 2,452 shares November 6, 2026

Weighted-average sale price $58.48 per share November 6, 2026

Sale price range $58.23 to $58.86 per share Multiple trades on November 6, 2026

Direct shares following sale 53,502 shares After the November 6, 2026 transaction

Key Terms

weighted average sales price

1 terms

weighted average sales price financial

"The price reported above reflects the weighted average sales price."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ATRC shares did director B. Kristine Johnson sell?

B. Kristine Johnson, a director, sold 2,452 shares of AtriCure common stock on November 6, 2026, at a reported weighted-average price of $58.48 per share; no Rule 10b5-1 plan is reported.

What was the price range for B. Kristine Johnson's ATRC share sale?

The shares were sold in multiple trades at prices ranging from $58.23 to $58.86 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JOHNSON B KRISTINE

(Last) (First) (Middle)

366 FERNDALE ROAD SOUTH

(Street)

WAYZATA MINNESOTA 55391

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/06/2026		S		2,452	D	$58.48(1)	53,502	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $58.23 to $58.86 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ B. Kristine Johnson	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)